Skip to main content
drug protocol number
RJ19/119/J
drug sponsor
King Abdullah International Medical Research Center (KAIMRC)
drug study
BRENTUXIMAB VEDOTIN , DOXORUBICIN HYDROCHLORIDE , VINBLASTINE SULPHATE , Dacarbazine
drug trial site
King Abdulaziz Medical City NG (Jeddah)
drug status
Rejected
drug phase